Research ArticleTheranostics
Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon and Andrei Iagaru
Journal of Nuclear Medicine April 2020, 61 (4) 546-551; DOI: https://doi.org/10.2967/jnumed.119.231654
Hong Song
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Caitlyn Harrison
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Heying Duan
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Kip Guja
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Negin Hatami
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Benjamin L. Franc
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Farshad Moradi
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Carina Mari Aparici
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Guido A. Davidzon
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Andrei Iagaru
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 4
April 1, 2020
Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon, Andrei Iagaru
Journal of Nuclear Medicine Apr 2020, 61 (4) 546-551; DOI: 10.2967/jnumed.119.231654
Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, Kip Guja, Negin Hatami, Benjamin L. Franc, Farshad Moradi, Carina Mari Aparici, Guido A. Davidzon, Andrei Iagaru
Journal of Nuclear Medicine Apr 2020, 61 (4) 546-551; DOI: 10.2967/jnumed.119.231654
Jump to section
Related Articles
Cited By...
- Diagnostic Performance of 68Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer
- Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
- Disparities in PET Imaging of Prostate Cancer at a Tertiary Academic Medical Center